Categories AlphaGraphs, Earnings, Health Care
Everything you need to know about Biogen’s (BIIB) Q1 2023 earnings
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the first quarter of 2023.
Total revenue declined 3% year-over-year to $2.46 billion. For the full year of 2023, the company expects revenues to decline in the mid-single digit percentage and projects adjusted earnings per share in the range of $15.00 to 16.00.
Net income attributable to Biogen Inc. was $387.9 million or $2.67 per share in Q1, compared to $303.8 million or $2.06 per share last year. Adjusted earnings declined 6% to $3.40 per share.
Prior Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
T Earnings: All you need to know about AT&T’s Q1 2024 earnings results
AT&T Inc. (NYSE: T) reported its first quarter 2024 earnings results today. Revenues dipped slightly to $30 billion from $30.1 billion in the year-ago quarter. Net income attributable to common
V Earnings: All you need to know about Visa’s Q2 2024 earnings results
Visa (NYSE: V) reported its second quarter 2024 earnings results today. Net revenue increased 10% year-over-year to $8.8 billion. GAAP net income grew 10% to $4.7 billion and EPS rose
Tesla (TSLA) reports lower Q1 revenue and earnings; results miss estimates
Electric vehicle giant Tesla Inc. (NASDAQ: TSLA) Tuesday reported lower revenues and earnings, on an adjusted basis, for the first quarter of 2024. The Austin-based carmaker said its first-quarter revenues
